Ifosfamide, paclitaxel and cisplatin first-line chemotherapy in advanced, suboptimally debulked epithelial ovarian cancer.

@article{Papadimitriou2001IfosfamidePA,
  title={Ifosfamide, paclitaxel and cisplatin first-line chemotherapy in advanced, suboptimally debulked epithelial ovarian cancer.},
  author={Christos Papadimitriou and Charalambos Kouroussis and Lia Angela Moulopoulos and George E. Vlahos and Alexandros J Rodolakis and Ch Kiamouris and Emmanuel S Diakomanolis and Dimitros Gika and Stylianos Michalas and Meletios Athanasios Dimopoulos},
  journal={Cancer},
  year={2001},
  volume={92 7},
  pages={1856-63}
}
BACKGROUND The combination of paclitaxel with a platinum analogue is the preferred chemotherapy regimen in the treatment of advanced epithelial ovarian carcinoma. The alkylating agent ifosfamide has shown activity in refractory or recurrent ovarian cancer. We conducted a Phase II study with the combination of ifosfamide, paclitaxel, and cisplatin for the… CONTINUE READING